Carregant...
Rheumatic immune‐related adverse events induced by immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) block the major inhibitory pathways in T cells, resulting in an augmented antitumor response. Immune‐related adverse events (irAEs) are a new class of side effects caused by ICIs and tend to be more prevalent in patients with preexisting autoantibodies and autoimm...
Guardat en:
| Publicat a: | Asia Pac J Clin Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246553/ https://ncbi.nlm.nih.gov/pubmed/32717098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajco.13346 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|